Gliotoxin-induced changes in rat liver regeneration after partial hepatectomy

Liver International

Volumn 33, Issue 7, 2013, Pages 1044-1055

  Nejak Bowen, Kari N ^a   Orr, Anne V ^a   Bowen Jr, William C ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Desmin; Extracellular matrix; Hepatocyte growth factor; Liver regeneration; Proliferation; Stellate cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN ALPHA 1 TYPE I; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE V ALPHA 2; DESMIN; GLIOTOXIN; PROCOLLAGEN TYPE I ALPHA 1; PROCOLLAGEN TYPE I ALPHA 2; PROCOLLAGEN TYPE XII ALPHA 1; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HEPATIC NON PARENCHYMAL CELL; LIVER CELL; LIVER REGENERATION; MALE; MITOSIS; NONHUMAN; PARTIAL HEPATECTOMY; PH; PHENOTYPE; PROTEIN EXPRESSION; RAT;

APOPTOSIS; DESMIN; EXTRACELLULAR MATRIX; HEPATOCYTE GROWTH FACTOR; LIVER REGENERATION; PROLIFERATION; STELLATE CELLS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DNA PRIMERS; ENDOTHELIAL CELLS; GLIOTOXIN; HEPATECTOMY; HEPATIC STELLATE CELLS; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; LIVER REGENERATION; MACROPHAGES; ORGANIC CHEMICALS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84880139988     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12164     Document Type: Article

References (56)

1. Higgins GM, Anderson RM. Experimental pathology of the liver, 1: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.
2. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300.
3. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
4. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001; 34(4 Pt 1): 688-93.
5. Schirmacher P, Geerts A, Jung W, et al. The role of Ito cells in the biosynthesis of HGF-SF in the liver. EXS 1993; 65: 285-99.
6. Lecouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003; 299: 890-3.
7. Zarnegar R, Defrances MC, Kost DP, Lindroos P, Michalopoulos GK. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991; 177: 559-65.
8. Rana B, Mischoulon D, Xie Y, Bucher NL, Farmer SR. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Mol Cell Biol 1994; 14: 5858-69.
9. Rudolph KL, Trautwein C, Kubicka S, et al. Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. Hepatology 1999; 30: 1159-66.
10. Gallai M, Sebestyen A, Nagy P, et al. Proteoglycan gene expression in rat liver after partial hepatectomy. Biochem Biophys Res Commun 1996; 228: 690-4.
11. Nakatsukasa H, Evarts RP, Hsia CC, Thorgeirsson SS. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 1990; 63: 171-80.
12. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-69.
13. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003; 28: 105-12.
14. Pahl HL, Krauss B, Schulze-Osthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183: 1829-40.
15. Orr JG, Leel V, Cameron GA, et al. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology 2004; 40: 232-42.
16. Kweon YO, Paik YH, Schnabl B, et al. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 2003; 39: 38-46.
17. Anselmi K, Stolz DB, Nalesnik M, et al. Gliotoxin causes apoptosis and necrosis of rat Kupffer cells in vitro and in vivo in the absence of oxidative stress: exacerbation by caspase and serine protease inhibition. J Hepatol 2007; 47: 103-13.
18. Elsharkawya M, Wright MC, Hay RT, et al. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology 1999; 30: 761-9.
19. Hagens WI, Olinga P, Meijer DK, et al. Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int 2006; 26: 232-9.
20. Elsharkawya M, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005; 10: 927-39.
21. Wright MC, Issa R, Smart DE, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685-98.
22. Dekel R, Zvibel I, Brill S, et al. Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci 2003; 48: 1642-7.
23. Hagens WI, Beljaars L, Mann DA, et al. Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther 2008; 324: 902-10.
24. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999; 59: 3954-60.
25. Block GD, Locker J, Bowen WC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996; 132: 1133-49.
26. Bhave VS, Paranjpe S, Bowen WC, et al. Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo. Hepatology 2011; 54: 1360-70.
27. Vogel S, Piantedosi R, Frank J, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000; 41: 882-93.
28. Zeng G, Apte U, Cieply B, Singh S, Monga SP. SiRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007; 9: 951-9.
29. Nejak-Bowen K, Kikuchi A, Monga SP. Beta-catenin-NF-kappaB interactions in murine hepatocytes: a complex to die for. Hepatology 2013; 57: 763-74.
30. Carotti S, Morini S, Corradini SG, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl 2008; 14: 806-14.
31. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. Faseb J 1996; 10: 413-27.
32. Muller M, Morotti A, Ponzetto C. Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol 2002; 22: 1060-72.
33. Song HH, Filmus J. The role of glypicans in mammalian development. Biochim Biophys Acta 2002; 1573: 241-6.
34. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-8.
35. Kalinichenko VV, Bhattacharyya D, Zhou Y, et al. Foxf1 + /- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 2003; 37: 107-17.
36. Issa R, Zhou X, Trim N, et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 2003; 17: 47-9.
37. Greene AK, Wiener S, Puder M, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003; 237: 530-5.
38. Wang L, Wang X, Xie G, Hill CK, Deleve LD. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. J Clin Invest 2012; 122: 1567-73.
39. Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Loss of NF-kappaB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1570-7.
40. Boulton RA, Alison MR, Golding M, Selden C, Hodgson HJ. Augmentation of the early phase of liver regeneration after 70% partial hepatectomy in rats following selective Kupffer cell depletion. J Hepatol 1998; 29: 271-80.
41. Michalopoulos GK, Defrances MC. Liver regeneration. Science 1997; 276: 60-6.
42. Albrecht JH, Hu MY, Cerra FB. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun 1995; 209: 648-55.
43. Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem 2001; 76: 1497-508.
44. Seol DW, Chen Q, Zarnegar R. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Oncogene 2000; 19: 1132-7.
45. Fitzgerald MJ, Webber EM, Donovan JR, Fausto N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995; 6: 417-27.
46. Guttridge DC, Albanese C, Reuther JY, Pestell RG. Baldwin AS. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999; 19: 5785-99.
47. Plumpe J, Malek NP, Bock CT, et al. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 2000; 278: G173-83.
48. Paranjpe S, Bowen WC, Bell AW, et al. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 2007; 45: 1471-7.
49. Shen K, Chang W, Gao X, et al. Depletion of activated hepatic stellate cell correlates with severe liver damage and abnormal liver regeneration in acetaminophen-induced liver injury. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 307-15.
50. Benten D, Kumaran V, Joseph B, et al. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 2005; 42: 1072-81.
51. Apte U, Gkretsi V, Bowen WC, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009; 50: 844-51.
52. Liu B, Paranjpe S, Bowen WC, et al. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009; 175: 717-24.
53. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995; 96: 447-55.
54. Sakurai H, Nigam SK. Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am J Physiol 1997; 272(1 Pt 2): F139-46.
55. Ebrahimkhani MR, Oakley F, Murphy LB, et al. Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease. Nat Med 2011; 17: 1668-73.
56. Karp SJ. Clinical implications of advances in the basic science of liver repair and regeneration. Am J Transplant 2009; 9: 1973-80.